-

Piper Sandler Expands Restructuring Investment Banking Team with the Addition of Sam Karotkin

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Sam Karotkin as a managing director to its restructuring investment banking team.

“We are very excited to welcome Sam to the team. His strong leadership skills and extensive background in restructurings, both in and out of court, will be a great addition to our growing team and assist us in continuing to provide high quality advice and services to our clients,” said Todd Snyder, managing director and global head of restructuring investment banking at Piper Sandler.

Karotkin joins Piper Sandler with 10 years of investment banking experience. Previously, Karotkin was in the restructuring investment banking group at Rothschild & Co. He has a broad range of transactional experience, including company side and creditor assignments involving in court and out of court recapitalizations and refinancings, as well as M&A and strategic advisory representations. Karotkin graduated with a bachelor’s degree in economics from Tufts University and received his Master of Business Administration degree from New York University’s Leonard N. Stern School of Business.

“I am thrilled to be joining a premier restructuring advisory business and investment banking franchise. The Piper Sandler platform has tremendous resources and I am excited about the opportunity to collaborate with my colleagues and leverage the breadth and reputation of the full organization,” said Sam Karotkin.

The Piper Sandler restructuring group is an industry leading advisory team focused on financial restructurings, reorganizations and other complex financial transactions for public, private and governmental clients.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | Twitter

©2023. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Pamela Steensland
Tel: 612 303-8185
pamela.steensland@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Versions
$Cashtags

Contacts

Pamela Steensland
Tel: 612 303-8185
pamela.steensland@psc.com

Social Media Profiles
More News From Piper Sandler Companies

Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets. Mori will be based in Greenwich and Friel will be in New York, both reporting to Michael Piper, head of fixed income at Piper Sandler. The distressed debt and special asset group will source and trade specialized credit products, including distr...

Piper Sandler Companies Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per Share

MINNEAPOLIS--(BUSINESS WIRE)--The complete earnings release can be found on the firm's website at pipersandler.com/earnings...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Patrick McCormack

MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Patrick McCormack, M.D. as a managing director in the healthcare investment banking group. McCormack will be based in San Francisco and focused on advising biopharma companies on mergers and acquisitions and capital-raising transactions. “We are excited to welcome Patrick to the healthcare investment banking team. His deep expertise advising bioph...
Back to Newsroom